Nutritional supplements that may be helpful: Most research on
lysine has been done on people with cold sores or on groups that include both cold sores and
genital herpes sufferers. However, some evidence exists that supplemental lysine may be
effective in the prevention and treatment of genital herpes. In one preliminary survey, 81% of
people with HSV infections (including genital herpes) reported lysine was effective for
reducing recurrences and shortening healing time in amounts averaging about 1,000 mg per
day.4 A small double-blind trial of people with oral and genital herpes examined
the effects of 1,248 mg or 624 mg of lysine daily versus placebo.5 The study found
that 1,248 mg per day of lysine, but not the lower dose, was effective in reducing the
recurrence rate of herpes outbreaks by 57% to 65%, while neither dose helped reduce the
healing time. Another small double-blind trial found that using 3,000 mg per day of lysine in
divided doses led to a decrease in severity of symptoms and a reduction in healing time of
both oral and genital herpes.6 One preliminary report found no benefit of lysine
for a group of patients with either oral or genital herpes.7
In a test tube, zinc is capable of inactivating the type of
herpes virus responsible for the majority of genital herpes cases.8 Topical zinc
may therefore help prevent outbreaks of genital herpes. One preliminary study treated people
(four of whom had genital herpes) with a 4% zinc sulfate solution applied to the site of the
initial outbreak.9 In all cases, the pain, burning, and tingling stopped within 24
hours of beginning the topical zinc therapy. The use of lower concentrations of zinc
(0.025–0.05%) has also been shown effective against oral and genital herpes
outbreaks.10 11 While topical zinc has been shown to be helpful, there
is no convincing evidence that oral zinc offers the same benefits.12
Lithium is a mineral available in an ointment or in the prescription drug lithium carbonate. In small studies, pharmacological doses of
lithium carbonate have helped prevent outbreaks of genital herpes.13 14
However, there is no evidence that smaller amounts of oral lithium in nonprescription
supplements would be similarly effective. A controlled study using a topical ointment
containing 8% lithium succinate with 0.05% zinc sulphate diminished the pain and discomfort of
genital herpes and shortened the healing time.15 In light of the known benefits of
topical zinc, it is unclear whether lithium was an important component of this treatment
A test tube study found that flavonoids present in propolis are responsible for the supplement’s antiviral
action.16 A controlled study found that an ointment containing propolis, used four
times daily, was almost twice as effective as topical
antiviral medication or a placebo ointment.17
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
References:
1. Cohen F, Kemeny ME, Kearney KA, et al. Persistent stress as a
predictor of genital herpes recurrence. Arch Intern Med 1999;159:2430–6.
2. Tankersley RW. Amino acid requirements of herpes simplex virus in
human cells. J Bacteriol 1964;87:609–13.
3. Algert SJ, Algert SJ, Stubblefield NE, et al. Assessment of dietary
intake of lysine and arginine in patients with herpes simplex. J Am Diet Assoc
1987;87:1560–1.
4. Walsh DE, Griffith RS, Behforooz A. Subjective response to lysine in
the therapy of herpes simplex. J Antimicrob Chemother 1983;12:489–96.
5. McCune MA, Perry HO, Muller SA, O’Fallon WM. Treatment of
recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis
1984;34:366–73.
6. Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy
in frequently recurrent herpes simplex infection. Dermatologica
1987;175:183–90.
7. Simon CA, Van Melle GD, Ramelet AA. Failure of lysine in frequently
recurrent herpes simplex infection. Arch Dermatol 1985;121:1678 [letter].
8. Arens M, Travis S. Zinc salts inactivate clinical isolates of herpes
simplex virus in-vitro. J Clin Microbiol 2000;38:1758–62.
9. Wahba A. Topical application of zinc solutions: A new treatment for
herpes simplex infections of the skin? Acta Derm Venereol 1980;60:175–7.
10. Finnerty EF. Topical zinc in the treatment of herpes simplex.
Cutis 1986;37:130–1.
11. Brody I. Topical treatment of recurrent herpes simplex and
post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J
Derm 1981;104:191–4.
12. Eby GA, Halcomb WW. Use of topical zinc to prevent recurrent herpes
simplex infection: review of literature and suggested protocols. Med Hypotheses
1985;17:157–65.
13. Amsterdam JD, Maislin G, Hooper MB. Suppression of herpes simplex
virus infections with oral lithium carbonate—a possible antiviral activity.
Pharmacotherapy 1996;16:1070–5.
14. Amsterdam JD, Maislin G, Potter L, Giuntoli R. Reduced rate of
recurrent genital herpes infections with lithium carbonate. Psychopharmacol Bull
1990;26:343–7.
15. Skinner GRB. Lithium ointment for genital herpes. Lancet
1983;2:288 [letter].
16. Debiaggi M, Tateo F, Pagani L, et al. Effects of propolis flavonoids
on virus infectivity and replication. Microbiologica 1990;13:207–13.
17. Vynograd N, Vynograd I, Sosnowski Z. A comparative multi-centre study
of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV).
Phytomedicine 2000;7:1–6.
18. Pompei R, Flore O, Marccialis MA, et al. Glycyrrhizic acid inhibits
virus growth and inactivates virus particles. Nature 1979;281:689–90.
19. Csonka GW, Tyrrell DA. Treatment of herpes genitalis with
carbenoxolone and cicloxolone creams: a double blind placebo controlled clinical trial. Br
J Vener Dis 1984;60:178–81.
20. Partridge M, Poswillo D. Topical carbenoxolone sodium in the
management of herpes simplex infection. Br J Oral Maxillfac Surg
1984;22:138–45.
21. Wolbling RH, Leonhardt K. Local therapy of herpes simplex with dried
extract of Melissa officinalis. Phytomedicine 1994;1:25–31.
22. Syed TA, Afzal M, Ahmad SA, et al. Management of genital herpes in
men with 0.5% Aloe vera extract in a hydrophylic cream: a placebo-controlled,
double-blind study. J Dermatol Treat 1997;8:99–102.
23. Bourne KZ, Bourne N, Reising SF, Stanberry LR. Plant products as
topical microbicide candidates: assessment of in vitro and in vivo activity against herpes
simplex virus type 2. Antiviral Research 1999;42:219–26.
24. Cohen F, Kemeny ME, Kearney KA, et al. Persistent stress as a
predictor of genital herpes recurrence. Arch Intern Med 1999;159:2430–6.
25. Rand KH, Hoon EF, Massey JK, Johnson JH. Daily stress and recurrence
of genital herpes simplex. Arch Int Med 1990;150:1889–93.
26. Cohen F, Kemeny ME, Kearney KA, et al. Persistent stress as a
predictor of genital herpes recurrence. Arch Intern Med 1999;159:2430–6.
27. Longo DJ, Clum GA, Yaeger NJ. Psychosocial treatment for recurrent
genital herpes. J Consult Clin Psychol 1988;56:61–6.
28. Koehn KA, Burnette MM, Stark C. Applied relaxation training in the
treatment of genital herpes. J Behav Ther Exp Psychiatry 1993;24:331–41.
29. Gould SS, Tissler DM. The use of hypnosis in the treatment of herpes
simplex II. Am J Clin Hypn 1984;26:171–4.